| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Marshman Fund Trust II | 11% | $178,084,462 | 6,051,120 | Marshman Fund Trust II | 31 Dec 2024 | |||
| BlackRock, Inc. | 10% | -18% | $169,781,023 | -$35,290,072 | 5,768,978 | -17% | BlackRock, Inc. | 31 Mar 2025 |
| VANGUARD GROUP INC | 8.3% | $139,310,113 | 4,733,609 | The Vanguard Group | 31 Dec 2024 | |||
| FMR LLC | 6.7% | $106,022,551 | 3,846,972 | FMR LLC | 30 Sep 2025 |
As of 30 Sep 2025, 291 institutional investors reported holding 47,346,201 shares of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY). This represents 82% of the company’s total 57,417,494 outstanding shares.
The largest institutional shareholders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) together control 60% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 6,925,942 | +2.8% | 0% | $190,878,961 |
| VANGUARD GROUP INC | 8.9% | 5,097,176 | -0.27% | 0% | $140,478,171 |
| FMR LLC | 6.7% | 3,846,972 | -18% | 0.01% | $106,022,551 |
| DIMENSIONAL FUND ADVISORS LP | 2.9% | 1,691,581 | +6.9% | 0.01% | $46,620,388 |
| AMERICAN CENTURY COMPANIES INC | 2.9% | 1,669,565 | +11% | 0.02% | $46,013,211 |
| STATE STREET CORP | 2.9% | 1,653,604 | +1.5% | 0% | $45,573,326 |
| LSV ASSET MANAGEMENT | 2.8% | 1,594,893 | +7.1% | 0.1% | $43,955,000 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.3% | 1,295,381 | +43% | 0.02% | $35,700,700 |
| Valor Management LLC | 2.2% | 1,268,204 | -81% | 52% | $34,951,702 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,258,263 | +19% | 0% | $34,681,184 |
| RENAISSANCE TECHNOLOGIES LLC | 2% | 1,137,071 | +22% | 0.04% | $31,337,677 |
| MORGAN STANLEY | 1.5% | 847,895 | +12% | 0% | $23,367,997 |
| Boston Partners | 1.3% | 753,952 | +25% | 0.02% | $20,697,199 |
| GOLDMAN SACHS GROUP INC | 1.1% | 646,653 | -10% | 0% | $17,821,756 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.99% | 570,539 | -11% | 0% | $15,724,055 |
| UBS Group AG | 0.88% | 503,081 | +213% | 0% | $13,864,912 |
| venBio Partners LLC | 0.85% | 489,194 | 0% | 7.6% | $13,482,187 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.79% | 456,401 | +4.2% | 0% | $12,578,412 |
| NOMURA HOLDINGS INC | 0.76% | 437,163 | +3.4% | 0.06% | $12,048,212 |
| NORTHERN TRUST CORP | 0.75% | 432,761 | -0.27% | 0% | $11,926,893 |
| DEUTSCHE BANK AG\ | 0.74% | 425,701 | +89% | 0% | $11,732,320 |
| Invesco Ltd. | 0.7% | 403,288 | +0.58% | 0% | $11,114,618 |
| BNP PARIBAS FINANCIAL MARKETS | 0.69% | 395,144 | 0% | 0.01% | $10,890,169 |
| Pacer Advisors, Inc. | 0.63% | 362,948 | -4.5% | 0.03% | $10,002,847 |
| AQR CAPITAL MANAGEMENT LLC | 0.62% | 355,568 | +134% | 0.01% | $9,799,455 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,373,205 | $51,373,236 | +$39,602,178 | $37.42 | 22 |
| 2025 Q3 | 47,346,201 | $1,305,082,008 | -$113,331,632 | $27.56 | 291 |
| 2025 Q2 | 51,269,247 | $1,620,478,469 | +$22,306,889 | $31.60 | 276 |
| 2025 Q1 | 50,193,424 | $1,664,235,088 | -$100,697,267 | $33.19 | 267 |
| 2024 Q4 | 52,708,406 | $1,813,638,877 | +$62,320,767 | $34.41 | 244 |
| 2024 Q3 | 50,136,635 | $2,005,018,440 | +$11,121,046 | $40.00 | 231 |
| 2024 Q2 | 50,163,988 | $1,513,604,428 | +$34,652,893 | $30.17 | 218 |
| 2024 Q1 | 48,982,561 | $1,644,752,000 | +$41,053,934 | $33.58 | 206 |
| 2023 Q4 | 47,832,583 | $1,544,993,160 | -$51,074,763 | $32.30 | 219 |
| 2023 Q3 | 49,527,453 | $1,623,105,557 | -$85,461,798 | $32.77 | 203 |
| 2023 Q2 | 51,951,129 | $1,828,229,880 | +$28,751,282 | $35.19 | 207 |
| 2023 Q1 | 51,270,566 | $1,674,006,219 | -$29,571,258 | $32.65 | 213 |
| 2022 Q4 | 51,015,535 | $2,810,596,096 | +$34,893,529 | $55.10 | 238 |
| 2022 Q3 | 50,461,165 | $2,237,024,113 | +$91,703,030 | $44.29 | 195 |
| 2022 Q2 | 47,874,920 | $2,335,182,718 | +$99,684,851 | $48.77 | 173 |
| 2022 Q1 | 45,933,803 | $2,235,023,234 | +$79,981,090 | $48.65 | 168 |
| 2021 Q4 | 44,541,354 | $1,899,444,678 | +$107,131,256 | $42.64 | 138 |
| 2021 Q3 | 30,932,269 | $1,185,850,908 | +$116,456,188 | $38.33 | 99 |
| 2021 Q2 | 27,994,218 | $790,282,400 | -$7,611,822 | $28.23 | 79 |
| 2021 Q1 | 27,468,517 | $907,561,000 | -$18,485,709 | $33.04 | 55 |
| 2020 Q4 | 27,956,363 | $998,030,405 | -$18,654,367 | $36.15 | 59 |
| 2020 Q3 | 28,549,056 | $940,508,000 | +$940,508,000 | $33.90 | 44 |